Literature DB >> 20938629

[Therapy-refractory thrombocytopenia in a 28-year-old patient].

D Sauter1, H Ostermann, K Selleng, K Spiekermann.   

Abstract

We report a case of a patient with thrombocytopenia. A sporadic MYH9-associated disease, May Hegglin anomaly, was identified by giant platelets, leucocyte inclusion bodies and the typical distribution of NMMHC-IIA in granulocytes in the absence of impaired renal function, cataract and hearing loss. MYH9-associated diseases are an underestimated differential diagnosis of idiopathic thrombocytopenia. The correct diagnosis is important to prevent unnecessary treatment of a patient with thrombocytopenia and to provide sufficient patient information and genetic counseling. Therefore, careful examination of the blood smear has to be the first diagnostic step in a case of unexplained thrombocytopenia.

Entities:  

Mesh:

Year:  2011        PMID: 20938629     DOI: 10.1007/s00108-010-2656-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

Review 1.  Myosins: a diverse superfamily.

Authors:  J R Sellers
Journal:  Biochim Biophys Acta       Date:  2000-03-17

2.  Genotype-phenotype correlation in MYH9-related thrombocytopenia.

Authors:  Fan Dong; Sufeng Li; Núria Pujol-Moix; Naomi L C Luban; Sang Won Shin; Jae Hong Seo; Arlette Ruiz-Saez; Judit Demeter; Scott Langdon; Michael J Kelley
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

3.  Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

Authors:  A Tosetto; C L Balduini; M Cattaneo; E De Candia; G Mariani; A C Molinari; E Rossi; S Siragusa
Journal:  Thromb Res       Date:  2009-07-24       Impact factor: 3.944

4.  Perioperative management of a patient with May-Hegglin anomaly requiring craniotomy.

Authors:  Aasim S Sehbai; Jame Abraham; Vidya K Brown
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

5.  Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Authors:  M J Kelley; W Jawien; T L Ortel; J F Korczak
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).

Authors:  Kathleen Selleng; Lena E Lubenow; Andreas Greinacher; Theodore E Warkentin
Journal:  Eur J Haematol       Date:  2007-07-26       Impact factor: 2.997

Review 7.  [Congenital and acquired thrombocytopenias].

Authors:  R E Scharf
Journal:  Hamostaseologie       Date:  2003-11       Impact factor: 1.778

8.  Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.

Authors:  A K Rao; S Ghosh; L Sun; X Yang; J Disa; P Pickens; M Polansky
Journal:  Thromb Haemost       Date:  1995-10       Impact factor: 5.249

9.  MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.

Authors:  Marco Seri; Alessandro Pecci; Filomena Di Bari; Roberto Cusano; Maria Savino; Emanuele Panza; Alessandra Nigro; Patrizia Noris; Simone Gangarossa; Bianca Rocca; Paolo Gresele; Nicola Bizzaro; Paola Malatesta; Pasi A Koivisto; Ilaria Longo; Roberto Musso; Carmine Pecoraro; Achille Iolascon; Umberto Magrini; Juan Rodriguez Soriano; Alessandra Renieri; Gian Marco Ghiggeri; Roberto Ravazzolo; Carlo L Balduini; Anna Savoia
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.